Martin I. Freed

Insider Reports History

Entity
Individual
Location
87 Cambridgepark Drive, Cambridge, MA
Signature
/s/ by David Tyronne Howton as attorney-in-fact for Martin I Freed
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Martin I. Freed:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Solid Biosciences Inc. Director Director Stock Option (Right to Buy) 34.4K Jun 11, 2024 Direct
Dicerna Pharmaceuticals Inc Director Common Stock 0 $38.25 Dec 28, 2021 Direct
Dicerna Pharmaceuticals Inc Director Director Stock Option (Right to Buy) 0 Dec 28, 2021 Direct
Dicerna Pharmaceuticals Inc Director Restricted Stock Units 0 Dec 28, 2021 Direct

Insider Reports Filed by Martin I. Freed

Symbol Company Period Transactions Value $ Form Type Date Filed Role
SLDB Solid Biosciences Inc. Jun 11, 2024 1 $0 4 Jun 13, 2024 Director
SLDB Solid Biosciences Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Director
SLDB Solid Biosciences Inc. Dec 13, 2022 1 $0 4 Dec 15, 2022 Director
SLDB Solid Biosciences Inc. Jun 7, 2022 1 $0 4 Jun 9, 2022 Director
DRNA Dicerna Pharmaceuticals Inc Dec 28, 2021 8 -$127K 4 Dec 29, 2021 Director
SLDB Solid Biosciences Inc. Jun 16, 2021 1 $0 4 Jun 21, 2021 Director
DRNA Dicerna Pharmaceuticals Inc Jun 3, 2021 4 $0 4 Jun 7, 2021 Director